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ABSTRACT
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is very 
sensitive to radiotherapy. To date, the underlying mechanism remains poorly 
understood. Here, we demonstrated that expression of EBV-encoded microRNA 
BART7 (ebv-miR-BART7) increases responsiveness of NPC to radiation treatment by 
targeting GFPT1/TGFβ1 signaling. GFPT1 is the the key rate-limiting enzyme of the 
hexosamine signaling pathway and governs TGFβ1 production. TGFβ1, a pleotropic 
cytokine with the potency to trigger self-renewal and damage-repair machinery in 
somatic cells. TGFβ1 can protect zebrafish embryo from the lethal effects of radiation 
treatment. In silico analysis showed that ebv-miR-BART7 could target GFPT1 
transcript. Correlation analysis on primary NPC tissues suggested that ebv-miR-BART7 
and GFPT1 have negative expression correlation. Expression of GFPT1 and TGFβ1 
were inducible by radiation in NPC cell with ebv-miR-BART7 expression. Further, 
suppressing endogenous GFPT1 expression inhibited TGFβ1 which subsequently 
increased the responsiveness of NPC to radiation treatment. Taken together, our 
results demonstrated that ebv-miR-BART7 controls TGFβ1 production by targeting 
GFPT1. Detection of ebv-miR-BART7 may provide useful indicator for monitoring NPC 
progression and predict therapeutic outcomes.  
INTRODUCTION
Nasopharyngeal carcinoma (NPC) is endemic in 
Southeast Asia and southern China [1, 2]. Guangdong 
province in the southern China has the highest incidence 
worldwide [3]. Histologically, NPC are classified into 3 
sub-types including keratinizing squamous-cell carcinoma 
(type I), non-keratinizing squamous carcinoma (type II) 
and undifferentiated carcinoma (type III) [2]. Treatment 
for NPC is primarily based on radiotherapy [2]. Efficacy 
of radiotherapy or sensitivity of NPC to radiotherapy 
will have a direct impact on treatment outcome [4, 5]. 
Failure of radiotherapy will lead to disease recurrence or 
metastasis [6]. Despite of the encouraging results of NPC 
radiotherapy, recurrence of NPC after initial treatment 
remains obvious in particular regions with incidence 
ranging from from 8%-58% [5].  So far, the mechanisms 
governing the sensitivity of NPC to radiotherapy remains 
poorly understood. 
NPC is characterized by the close association with 
Epstein-Barr virus (EBV) infection and the oncogenic 
functions of EBV is well documented [7]. Recently, it 
was found that the small microRNA encoded by the EBV 
genome is a new class of oncogenic promoter which plays 
a key role in tumor development.  MicroRNA did no code 
for protein. Mature microRNA inhibits protein expression 
by promoting target mRNA degradation and/or inhibit 
the translation process [8]. Deep sequencing analysis 
identified 44 EBV-encoded microRNA in the NPC tissues 
[9]. Our previous study revealed that ebv-miR-BART7 
was expressed at high level in the undifferentiated NPC 
tissues. In addition, cell-free circulating ebv-miR-BART7 
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was detectable in the peripheral blood of NPC patients 
[10, 11]. Patients with ebv-miR-BART7 positive margins 
had a significantly higher chance of developing local 
tumor recurrence [12]. The data reveals that ebv-miR-
BART7 is important in the pathogenesis of NPC. 
NPC cells expressing ebv-miR-BART7 is more 
susceptible to radiation treatment [11]. Here, we 
demonstrated that expression of EBV-encoded microRNA 
BART7 (ebv-miR-BART7) increases responsiveness of 
NPC to radiation treatment by targeting GFPT1/TGFβ1 
signaling. GFPT1 is the the key rate-limiting enzyme of 
the hexosamine signaling pathway and governs TGFβ1 
production [13]. TGFβ1, a pleotropic cytokine with the 
potency to trigger self-renewal and damage-repair machinery 
in somatic cells [14]. In silico analysis showed that ebv-miR-
BART7 could target GFPT1 transcript. Correlation analysis 
on primary NPC tissues suggested that ebv-miR-BART7 and 
GFPT1 have negative expression correlation. Expression of 
GFPT1 and TGFβ1 were inducible by radiation in NPC. The 
data indicated that ebv-miR-BART7 could possibly mediate 
TGFβ1 production by targeting GFPT1.  
RESULTS
GFPT1 is a target gene of ebv-miR-BART7 
We hypothesized that ebv-miR-BART7 expressing 
NPC response differently as compared with the ebv-miR-
BART7 negative NPC after radiation treatment. Thus, we 
employed microarray to evaluate the transcriptomic changes 
of ebv-miR-BART7 expressing HONE1 and the mock 
transfectant after receiving cellular irradiation at 4 Gy. As 
microRNA is a negative gene regulator, we only focus on 
genes which showed differential reduced after irradiation. 
Using fold change 1.5-fold and P < 0.05 as cut-off, 73 
genes were significantly reduced in the ebv-miR-BART7 
expressing HONE1 after receiving radiation treatment. 
On the other hand, we performed computational 
prediction using Vir-Mir db to identify potential ebv-
miR-BART7 target genes.  Minimum free energy (mfe) 
was used to evaluate the stability of ebv-miR-BART7/
mRNA duplex. Using -25.0 kcal/mol mfe as cut-off, 1536 
genes were identified as potential target genes of ebv-
miR-BART7. Of which, 7 genes (GFPT1, GLS, HCN3, 
MID1, SCUBE3, SEMA3D, SLC25A29) matched with 
the gene list obtained from the microarray experiments 
(Figure 1A). QPCR analysis showed that ebv-miR-BART7 
expressing HONE1 had a significant reduction of GFPT1 
transcript level (Figure 1B).  To corroborate the findings, 
we measured ebv-miR-BART7 and GFPT1 transcript 
level in primary NPC tissues (prior treatment) and 
normal nasopharyngeal epithelia (Figure 1C). In the NPC 
tissues, ebv-miR-BART7 was expressed at high levels 
(P < 0.001). In contrast, GFPT1 was significantly reduced 
in comparison with the normal counterparts (p = 0.027). 
Furthermore, as shown in Figure 1D, expression of ebv-
miR-BART7 and GFPT1 showed negative correlation 
(Correlation coefficient = -0.47, p = 0.002). In ebv-miR-
BART7 negative NPC cell lines, both mRNA and protein 
expression levels of GFPT1 and the downstream regulated 
gene TGFβ1 were induced in response to radiation 
treatment at the dose of 4 Gy (Figure 1E). 
Sequence analysis indicated that the seed sequence 
of ebv-miR-BART7 could bind to 3′UTR of GFPT1 at 
2 sites: 15-36 and 1856-1877 (Figure 1F). In HONE1, 
restored ebv-miR-BART7 in the EBV-negative cell line 
using synthetic ebv-miR-BART7 mimic could reduce 
GFPT1 protein level (Figure 1G). To further confirm the 
post-transcriptional regulatory role of ebv-miR-BART7 
on GFPT1, we constructed luciferase reporter constructs 
containing either wild-type or mutant 3′untranslated 
region (UTR) of GFPT1 and transfected into HONE1 
cells. If ebv-miR-BART7 could target the predicted sites, 
transfection of ebv-miR-BART7 mimics shall bind and 
reduce the luciferase activity. As shown in Figure 1H, 
transfection of ebv-miR-BART7 mimic decreased the 
luciferase activity in cells with wild-type transcript. As 
the ebv-miR-BART7 are not specific to the binding sites 
of mutant construct, the inhibitory effect on luciferase 
activity was not observed in cell transfected with mutant 
luciferase reporter constructs.
GFPT1 knockdown reduces TGFβ1 production 
by NPC
EBV is present in all the undifferentiated NPC 
tissue samples. In comparison, EBV genome and the 
viral gene products is lost during continued passaging in 
most of the cell line models. At present, C666 is the only 
established NPC cell line harboring the viral genome and 
expressing ebv-miR-BART7 [15]. To explore the role of 
EBV in mediating TGFβ1 production, we extracted the 
absolute expression value of TGFβ1 in NPC tissues and 
cell lines in microarray datasets in public domains. All the 
EBV containing samples including primary NPC tissues 
and C666 demonstrated low expression level of TGFβ1. 
In contrast, the EBV-negative cells (HONE1, CNE1, 
& CNE2) had remarkable higher TGFβ1 expression 
(Figure 2A). To examine whether the reduced TGFβ1 in 
EBV-positive samples was attributed to ebv-miR-BART7, 
we examined the expression changes of TGFβ1 in NPC 
cells after transfection with ebv-miR-BART7 mimics. 
Significant reduction in TGFβ1 mRNA and protein 
level were observed in the transfectants (Figure 2B). In 
addition, TGFβ1 level in EBV-negative cells could also 
be suppressed with the use of GFPT1 siRNA (Figure 2C). 
Overall, the data suggested that ebv-miR-BART7 inhibited 
TGFβ1 production by targeting GFPT1.
Oncotarget20299www.impactjournals.com/oncotarget
TGFβ1 confers radiation protection to NPC
Having demonstrated the relationship between 
ebv-miR-BART7 and TGFβ1, we tested whether TGFβ1 
could affect the sensitivity of NPC cells to radiation. 
NPC cells were treated with recombinant TGFβ1 before 
radiation treatment. HONE1 was treated with recombinant 
TGFβ1 at 10 ng/ml. For HK1, the cells were incubated 
with TGFβ1 at 0.5 ng/ml because TGFβ1 higher than this 
level could had growth inhibitory effect (data not shown). 
The colony forming ability of pre-treated cells was higher 
in comparison with the parallel control. In addition, the 
colony forming ability is remarkable higher in the pre-
treated cells exposing to high-dose radiation (Figure 3A). 
To confirm the results, radiation treatment was repeated on 
NPC cells transfected with TGFβ1 siRNA. Significantly 
reduction in the number of colony following radiation 
was observed in both HONE1 and HK1 cells transfected 
with TGFβ1 siRNA (Figure 3B). In addition, TGFβ1 
knockdown cells were more susceptible to radiation-
induced DNA damages. In comparison with the cells 
transfected with scramble siRNA, the number of γH2AX 
foci increased in the TGFβ1 knockdown cells in a dose-
dependent manner (Figure 3C). To confirm the protective 
Figure 1: EBV-encoded microRNA BART7 targeting GFPT1 in NPC. (A) Integration of microarray results and computational 
prediction identified ebv-miR-BART7 target genes. GFPT1 was significantly reduced in ebv-miR-BART7 expressing HONE1 after irradiation 
at 4 Gy. Computation prediction using ebv-miR-BART7 seed sequence suggested that GFPT1 transcript could form thermodynamically 
stable duplex with ebv-miR-BART7; (B) Reduced GFPT1 in irradiated HONE1 is confirmed by QPCR analysis. GAPDH was used as 
internal controls; (C) Expression level of ebv-miR-BART7 and GFPT1 between primary NPC (n = 42) and healthy controls (n = 29) were 
shown in the box plots. Elevated ebv-miR-BART7 was found in the primary NPC tissues without subjected to radiotherapy treatment. In 
comparison with the normal nasopharyngeal epithelia, GFPT1 level was significantly reduced in NPC; (D) Significant negative correlation 
was observed between ebv-miR-BART7 and GFPT1 level in NPC tissues; (E) QPCR and Western blot analysis showed that GFPT1 and 
TGFβ1 level was elevated in NPC cells following radiation at 4 Gy; (F) Predicted ebv-miR-BART7 binding sites on the 3′-UTR of GFPT1 
mRNA transcript; (G) Western blot and immunostaining analysis showed that GFPT1 protein was significantly reduced in HONE1 cells 
transfected with ebv-miR-BART7 mimic; (H) Results of luciferase reporter assay showed that ebv-miR-BART7 binds to the 2 sites on 
GFPT1 transcript. Two predicted regions of wild-type and mutant 3′-UTR of GFPT1 were cloned into pMIR-REPORT Luciferase vector to 
generate Luc-wild-type vector and Luc-mutant vector, respectively. Then. HONE1 cells were co-transfected with Luc-wild-type vector or 
Luc-mutant vector, BART7 mimic or negative control and pMIR-REPORT β-galactosidase control vector. Tansfected cells were measured 
for changes in firefly luciferase and β-galactosidase activities. **P < 0.01. 
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effect of TGFβ1 in vivo, we examined the lethal effects 
of radiation on zebrafish embryos with or without pre-
incubation with TGFβ1. The percentage survival of the 
zebrafish embryos was significantly reduced in comparison 
with the sham control. In the group with TGFβ1 pre-
treatment, radiation-induced death was also observed. 
However, the percentage survival of the embryos was 
significantly higher as compared with the group without 
receiving TGFβ1 pre-treatment (Figure 3D). 
TGFβ1 impacts on proliferation, apoptosis, and 
autophagy following irradiation  
Real-time cellular kinetic study showed that TGFβ1 
knockdown cells had reduced proliferation capacity in 
comparison with the mock transfectant following radiation 
(Figure 4A). Recombinant TGFβ1 treatment decreased 
the percentage of apoptotic cells induced by radiation 
(Figure 4B). We attempted to identify apoptosis-related 
genes using Cell-Death PCR Array. We followed the 
gene selected by the Cell Death PathwayFinder (https://
www.qiagen.com/hk/shop/pcr/primer-sets/rt2-profiler-pcr-
arrays?catno=PAHS-212Z#geneglobe) and test the gene 
expression changes in the NPC cells. In the presence of 
TGFβ1, the pro-apoptotic genes (ATP6VIG2, BCL2L11, 
CD40, SYCP2) were significantly reduced after irradiation. 
On the other hand, the anti-apoptotic genes (AKT1, 
BCL2L1, IGFIR, XIAP) were increased significantly after 
irradiation (Figure 4C). Formation of acidic vesicular 
organelles (AVO) after radiation is another indicator of 
radiation sensitivity of cancer cells [16]. Cells pretreated 
by TGFβ1 exhibited significantly lower number of AVO 
implicating that they are more resistant to radiation 
(Figure 4D). In transfectant containing TGFβ1 siRNA, 
significantly higher number of AVO suggested that they 
were more sensitive to radiation treatment (Figure 4E).
GFPT1 knockdown sensitizes NPC cells to 
radiation treatment 
As shown in Figure 1E, GFPT1 expression was 
induced following radiation treatment in NPC cells 
without ebv-miR-BART7 expression. Irradiated GFPT1 
knockdown NPC cells resulted in low number of colony 
Figure 2: Expression of TGFβ1 and the association with ebv-miR-BART7 and GFPT1. (A) Absolute expression level of 
TGFβ1 revealed by microarray datasets obtained from GEO; (B) QPCR, Western blot and immunostaining of TGFβ1 level in NPC cells 
transfected with ebv-miR-BART7 mimics showed significant reduction in both RNA and protein levels; (C) Expression reduction of 
TGFβ1 in NPC cells transfected with GFPT1 siRNA. **P < 0.01. 
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in both HONE1 and HK1 cells (Figure 5A). GFPT1 
knockdown cells had a higher number of γH2AX foci as 
opposed to the mock control suggesting that more DNA 
double-strand break was induced by radiation (Figure 5B). 
In addition, silence of GFPT1 in NPC cells increased 
the percentage of cells that exhibited autophagy under 
radiation treatment (Figure 5C).
Ebv-miR-BART7 regulates GFPT1-TGFβ1 
pathway and enhances radiation sensitivity
First, we transfected ebv-miR-BART7 into NPC cell 
lines and measured the changes of GFPT1 and and TGFβ1 
protein. Western blot data shown that GFPT1 and TGFβ1 
protein level was significantly reduced in ebv-miR-
BART7 expressing HONE1 and HK1 cells (Figure 6A). 
The suppressing effects of ebv-miR-BART7 on GFPT1 
and and TGFβ1 was reduced in NPC cells containing 
GFPT1 over-expressing vector (Figure 6A).  Next, we 
attempted to evaluate whether the increased in radiation 
sensitivity contributed by ebv-miR-BART7 in NPC cells 
could be rescued in the GFPT1-overexpressing NPC cell 
lines. As shown in Figure 6B, the colony forming ability of 
NPC cells transfected with ebv-miR-BART7 mimics was 
significantly reduced after irradiation. The colony forming 
ability was increased in the GFPT1 overexpressing cells. 
Taken together, the data suggested that ebv-miR-BART7-
GFPT1-TGFβ1 pathway is controlling radiation sensitivity 
in NPC cells. 
DISCUSSION
As EBV-positive NPC is more responsive to 
radiotherapy, we suggested that expression of EBV-
encoded microRNA is functionally important to the 
sensitivity of NPC cells to radiation treatment. Ebv-Mir-
BART7 is encoded by the BamHI A cluster in the EBV 
viral genome.  High expression of ebv-miR-BART7 is 
Figure 3: TGFβ1 conferred radiation protection to NPC cells. (A) Colony formation in NPC cells pre-treated with recombinant 
TGFβ1 before irradiation; (B) Reduced colony formation ability in TGFβ1 siRNA transfectant following radiation treatment; (C) TGFβ1 
knockdown using siRNA was performed in HONE1 and HK1 cells. The number of rH2AX foci formation of HONE1 and HK1 cells in the 
irradiated cells were counted; (D) TGFβ1 pre-treatment improved survival of zebarfish embryo receiving radiation treatment. *P < 0.05; 
**P < 0.01.
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noticed in the primary NPC tissues and circulation of NPC 
patients [17, 18]. Further, ebv-miR-BART7 expression is 
also found in other EBV-associated malignancies such as 
gastric carcinoma [19]. 
TGFβ1 is a pleotropic cytokine with the potency to 
trigger self-renewal and damage-repair machinery. Our 
data revealed that the proliferative inhibitory effects of 
radiation on NPC is prominently reduced in the presence 
of TGFβ1. Moreover, TGFβ1 knockdown NPC cells is 
more susceptible to radiation-induced DNA damages. 
TGFβ1 expression is associated with local tumor relapse 
and survival of NPC patients [20]. TGFβ1 could reduce 
ionizing radiation (IR)-induced DNA damage [21]. In 
mink lung epithelial cell line, activation of the TGFβ1 
signaling cascade with exogenous TGFβ1 could inhibit 
apoptosis induced by gamma-irradiation [22]. Hence, 
tumour microenvironment with high TGFβ1 content shall 
favour NPC escape from the “killing effect” of exogenous 
radiation treatment. 
TGFβ1 production is accompanied with increased 
activity in hexosamine biosynthesis pathway. The end 
product of hexosamine pathway, UDP-GlcNAc, modulates 
transcription regulators by O-glycosylation at specific 
activating sites (serine or threonine residues). Multiple 
glycosylated proteins are reported to be involved in TGFβ1 
up-regulation. Glycosylated Sp1 could activate TGFβ1 
expression by increasing the promoter activity. In addition, 
glycosylated PKCB could activate MAPK signalling 
cascade by stimulating p38 MAPK phosphorylation which 
will subsequently bind to TGFβ1 promoter and activate 
TGFβ1 transcription [23, 28]. In mesothelial cells, glucose 
functions as a strong effector in modulating TGFβ1 
upregulation [24]. Therefore, controlling the rate-limiting 
enzyme of hexosamine pathway could regulate TGFβ1 
expression in NPC. 
Using PCR array, we demonstrated that TGFβ1 is 
involved in the radiation responses by suppressing the 
pro-apoptotic genes in the NPC. The association of these 
Figure 4: TGFβ1 impacts on proliferation, apoptosis, and autophagy. (A) QPCR and Western blot analysis showing TGFβ1 
mRNA levels in HONE1 and HK1 cells transfected with TGFβ1 siRNA. Proliferation kinetics of NPC cells transfected with TGFβ1 
siRNA and mock control after receiving radiation treatment was measured continuously by xCELLigence Real-Time Cell Analyzer; 
(B) Representative dot plots of apoptotic cells of irradiated HONE and HK1 with or without recombinant TGFβ1 pre-treatment were 
analyzed by flow cytometry; (C) PCR array showing relative mRNA expression level of pro-apoptotic and anti-apoptotic genes in irradiated 
HONE1 and HK1 cells. GAPDH was employed as internal control; (D) AVO formation in NPC cells pretreated with recombinant TGFβ1 
under exposure to radiation. Percentage of cells with AVO formation was calculated; (E) AVO formation in NPC cells transfected with 
TGFβ1 siRNA upon radiation treatment. *P < 0.05; **P < 0.01.
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pro-apoptotic genes/ apoptotic-related genes with radiation 
responses has been demonstrated in several cancer models. 
For example, BCL2L11 (BIM) can regulate UV-induced 
apoptosis by controlling BAX activation [25]. Activated 
CD40 receptor can increase gamma-radiation induced 
apoptosis in multiple myeloma and B-lymphoma [26]. 
Inhibiting the AKT-regulated genes such as extra domain 
A (EDA) could enhance the radiation sensitivity of 
NPC cells [27]. High BCL2L1 expression is inversely 
correlated with the complete remission of oropharyngeal 
carcinoma patient treated with radical irradiation [28]. 
X-linked inhibitor of apoptosis protein (XIAP) can 
inhibit caspase-3, caspase-7, and caspase-9. In NPC 
cells, XIAP expression is induced by cell irradiation in 
a dose-dependent manner [29]. Thus, suppressing TGFβ1 
expression could target multiple radiation responsive 
signaling cascade in NPC cells and mediate the sensitivity 
of cancer cells to radiation treatment. 
Our findings established for the first time that ebv-
miR-BART7 suppressed the expression of GFPT1 and 
TGFβ1 that could reduce the sensitivity of NPC cells 
to radiation treatment. Targeting GFPT1 could suppress 
TGFβ1 production and increase the radiation sensitivity 
of NPC cells. Targeting GFPT1 and TGFβ1 may be a 
new strategy to enhance the radiosensitivity of NPC and 
improve treatment efficacy.  Further longitudinal study 
is warranted to establish the clinical association between 
ebv-miR-BART7 and the radiosensitivity or prognosis of 
NPC patients.  
MATERIALS AND METHODS
Cell cultures 
NPC cell lines HONE1 and HK1 were cultured in 
RPMI-1640 medium supplemented with 10% fetal bovine 
serum, 200 Unit/ml penicillin G sodium, 200 μg/ml 
streptomycin sulfate, and 0.5 μg/ml amphotericin B. 
HONE1 was established from a poorly differentiated 
nasopharyngeal carcinoma [30]. HK1 was derived from a 
well-differentiated nasopharyngeal carcinoma [31]. Cells 
were incubated at 37°C in a humidified incubator with 5% 
CO2. Cell irradiation was carried out by Gammacell
® 3000 
Elansystem (Best Theratronics Ltd.). 
Figure 5: Knockdown GFPT1 sensitized HONE1 and HK1 cells to radiation. (A) Colony formation ability of the irradiated 
HONE1 and HK1 cells transfected with GFPT1 siRNA; (B) rH2AX foci formation in nuclei of NPC cells transfected with GFPT1 siRNA; 
(C) Representative photos showed formation of acidic vesicular organelles (AVO) of HONE1 and HK1 cells transfected with GFPT1 
siRNA upon radiation treatment. *P < 0.05; **P < 0.01.
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Clinical samples
Primary NPC and normal nasopharyngeal epithelia 
were collected from the Department of Surgery, The 
University of Hong Kong, Queen Mary Hospital, Hong 
Kong. Institutional Review Board of the hospital has 
approved this collection protocol (registered number: UW 
10-142). For 42 patients with primary NPC, there were 
32 males and 10 females. Their ages ranged from 12-75 
years. For the 29 healthy volunteers, there were 20 males 
and 9 females and their ages ranged from 6–81 years.
Microarray and in silico analysis
The RNA quality assessment and gene expression 
microarray were performed in the Genome Research 
Centre of the University of Hong Kong. GeneChip 
Human Genome U133 Plus 2.0 Array (Affymetrix) was 
employed to examine global gene expression profiling. 
Agilent 2100 bioanalyzer (Agilent Technologies) was 
used to evaluate RNA quality. GeneSpring GX version 
10.0 (Agilent Technologies) was employed to analyze 
microarray data. The microarry data have been deposited 
in NCBI’s Gene Expression Omnibus and are accessible 
through GEO Series accession number GSE79571. 
Microarray data of 31 NPC tissues were obtained from 
GSE12452 of GEO. Microarray data of HONE1, CNE1, 
CNE2 were obtained from GSE15047. Raw microarray 
data of C666-1 were obtained from GSE34573. All the 
microarray data were normalized and analyzed using Gene 
Expression Commons [32].  Targets of ebv-miR-BART7 
was predicted using Vir-Mir db [33]. The minimum free 
energy (mfe) of the miRNA/mRNA duplex was calculated 
and a lower mfe indicated greater stability of the miRNA/
mRNA duplex.
RNA extraction and real-time quantitative RT-
PCR (QPCR) analysis
Total RNA was extracted and purified using 
TRIZOL (Life Technologies). High Capacity cDNA 
Reverse Transcription Kit (Life Technologies) was used 
for cDNA synthesis. Primers and probes for QPCR were 
designed by Universal ProbeLibrary Assay Design Center 
(http://www.roche-applied-science.com/). Transcript levels 
were determined by qPCR on a LightCycler® 480 (Roche 
Applied Science). Table 1 listed the sequence of primers 
and probes used in in the current study. 
Western blot analysis
Total proteins were extracted using lysis buffer 
containing RIPA (1% Nonidet P-40, 0.1% SDS sodium 
dodecyl sulfate and 0.5% sodium deoxycholate), 1% 
phenylmethylsulfonyl fluoride (Roche Applied Science) 
and 2% protease inhibitor cocktail (Roche Applied 
Science). Protein concentrations were determined by 
BCA Protein Assay Kit (Pierce Biotechnology). Proteins 
were separated in polyacrylamide gel, transferred to 
polyvinylidene difluoride (PVDF) membrane (Millipore), 
and hybridized with anti-GFPT1 antibodies (Abcam) 
and anti-TGFβ1 antibodies (Abcam). Hybridization 
Figure 6: Ebv-miR-BART7 enhanced radiosensitivity by targeting GFPT1-TGFβ1 pathway. (A) Western blot analysis 
showing protein expression level of GFPT1 and TGFβ1 in NPC cells transfected with ebv-miR-BART7 mimic with or without GFPT1 
overexpression vector. (B) Colony formation of NPC cells transfected with ebv-miR-BART7 mimic with or without GFPT1 overexpression 
vector under exposure to radiation. *P < 0.05; **P < 0.01.
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signals were examined using ECL Plus Western Blotting 
Detection Reagents (Amersham Biosciences).
Immunocytochemistry
Cells seeded on chamber slide were washed with 
PBS and fixed with 4% paraformaldehyde. Cells were 
incubated with anti-GFPT1 antibodies (Abcam) or anti-
TGFβ1 antibodies (Santa Cruz Biotechnology) and 
CF™488A Secondary Antibody Conjugates (Biotium). 
The nucleus was stained by blue-fluorescent DAPI (Life 
Technologies). Slides were observed and analyzed with 
the fluorescence microscope (Nikon).
Luciferase reporter assay
Sense and anti-sense strands of 2 different regions 
of 3′-UTR of GFPT1 harboring the binding sites of ebv-
miR-BART7 were synthesized. The two single strands of 
3′-UTR of GFPT1 containing mutation in the binding sites 
of ebv-miR-BART7 were also synthesized. The sequences 
of wild-type and mutant 3′-UTR of GFPT1 were listed 
in Table 2. After annealing, the sense and anti-sense 
strands of wild-type or mutant 3′-UTR of GTPT1 were 
cloned into the SacI and HindIII sites of pMIR-REPORT 
Luciferase vector (Life Technologies). HONE1 cells were 
co-transfected with ebv-miR-BART7 mimics or negative 
control (Qiagen), luciferase vector containing wild-type 
or mutant 3′-UTR of GTPT1 as well as pMIR-REPORT 
β-galactosidase control vector (Life Technologies). 
Dual-Light luminescent reporter gene assay kit (Life 
Technologies) was employed to determine the firefly 
luciferase and β-galactosidase activities on a LB 96V 
microplate luminometer (EG & G Berthold).
Colony formation assay 
Cells were irradiated at a single dose of 2, 4, 6 or 
8 Gy and were seeded in a six-well plate with 600 cells in 
each well. After incubation for 14 days, cells were fixed 
with 70% ethanol and stained with 0.5% crystal violet. The 
numbers of colonies with more than 50 cells were counted.
Proliferation assay
RTCA DP instrument of xCELLigence Real-Time 
Cell Analyzer (Roche Applied Science) was used to 
examine proliferation of NPC cells. Cells were seeded 
on E-Plate 16 and were irradiated by Gammacell® 3000 
Elansystem (Best Theratronics Ltd.). The proliferation rate 
of NPC cells was monitored continuously and expressed 
as cell indexes.
H2AX phosphorylation detection
NPC cells were seeded on chamber slides and 
irradiated at a single dose of 2, 4, 6 or 8 Gy. Then, cells 
were washed, fixed and incubated with rabbit polyclonal 
anti-γH2AX antibodies (Abcam) and CF™488A Secondary 
Antibody Conjugates (Biotium). The nucleus was stained 
by DAPI (Life Technologies). F-actin was stained by Alexa 
Fluor® 635 phalloidin (Life Technologies). Slides were 
observed with the fluorescence microscope (Nikon) and 
the number of γH2AX foci in the cells was counted.
Acridine orange (AO) staining
Formation of acidic vesicular organelles (AVO) 
during autophagy process is detected by AO staining 
(Sigma). AVO will appear as fluoresced red, while the 
cytoplasm and nucleolus are fluoresced bright green and 
dim red. Stained cells were observed using a fluorescent 
microscope (Nikon) or analyzed using Cytomics™ FC 500 
(Beckman Coulter). The percentage of cells undergoing 
autophagy was calculated. 
Cell apoptosis by annexin V staining
Apoptotic cells were detected by Annexin V 
staining on the BD FACSCalibur Flow Cytometry System 
(BD Biosciences). Cells were irradiated, harvested, and 
resuspended in Annexin-binding buffer (10 mM HEPES, 
140 mM NaCl and 2.5 mM CaCl2, pH 7.4). Then, 
cells with stained with APC-labelled Annexin V (BD 
Biosciences) and 7-AAD (BD Biosciences) and analyzed 
by flow cytometry.
Animals
Embryo of wild type zebrafish AB line were 
maintained in standard zebrafish E3 embryo medium 
and irradiated following procedure described [34]. Cell 
irradiation was performed using Gammacell® 3000 
Elansystem (Best Theratronics Ltd.) at 4 hpf (hour post 
fertilization). The embryo was incubated in TGFβ1 
(10 ng/ml) containing E3 medium for 2 hours before 
radiation treatment. Continued embryo survival was 
assessed by cardiac contractility up to 9 days. Percentage 
survival was defined as the ratio between irradiated group 
and non-irradiated group (20 embryos per group). The 
study was approved by the Institutional Animal Use in 
Research Committee at the University of Hong Kong 
(reference number: 2939-13).
Overexpression of GFPT1 by lentivirus infection
Full-length GFPT1 coding sequence was cloned into 
lentiviral expression vector pCDH (System Biosciences) to 
generate the GFPT1-expressing vector. Vector sequences 
were verified by direct sequencing. Virus packaging was 
performed by transient transfection into 293T cells using 
Lipofectamine® 2000 Transfection Reagent (Invitrogen). 
NPC cell lines HONE1 and HK1 were transduced with 
medium containing lentivirus. 
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Table 1: Primer and probe sequences for QPCR
Gene Forward primer (5′–3′) Reverse primer (5′–3′) Probe number*
ABL1 GGGCTGCAAATCCAAGAAG ATGCTACTGGCCGCTGAA 78
AKT1 CCAGCCTGGGTCAAAGAAG CTGGCCACAGCCTCTGAT 16
APAF1 CCTGTTGTCTCTTCTTCCAGTGT AAAACAACTGGCCTCTGTGG 39
ATP6V1G2 AAGACCCAGGGGTAGTGGAG CCCCCACCGCTTACTTCT 78
BAX ATGTTTTCTGACGGCAACTTC ATCAGTTCCGGCACCTTG 57
BCL2 AGTACCTGAACCGGCACCT GCCGTACAGTTCCACAAAGG 75
BCL2A1 CAGGAGAATGGATAAGGCAAA CCAGCCAGATTTAGGTTCAAA 75
BCL2L1 AGCCTTGGATCCAGGAGAA AGCGGTTGAAGCGTTCCT 66
BCL2L11 GGCCCCTACCTCCCTACA GGGGTTTGTGTTGATTTGTCA 21
BIRC2 GATATTGTGTCAGCACTTCTTAATGC TCTGTTCTTCCGAATTAATGACAA 35
BIRC3 GCCCAGGAGATGAAAATGC CATGATTGCATCTTCTGAATGG 80
CASP1 CCAGGACATTAAAATAAGGAAACTGTA CCAAAAACCTTTACAGAAGGATCTC 1
CASP2 GGGGTCTTGGTCCACCTT GCCACACACTCCCAATATCC 17
CASP3 TGTGAGGCGGTTGTAGAAGA GGGCTCGCTAACTCCTCAC 76
CASP6 GATGCAGCCTCCGTTTACA CACAGTTTCCCGGTGAGAATA 40
CASP7 CCGAGACTTTTAGTTTCGCTTT CCTGATCATCTGCCATCGT 57
CASP9 GAACATCTTCAATGGGACCAG CAAACCCATGGTCTTTCTGC 64
CD40 GGTCTCACCTCGCTATGGTT CAGTGGGTGGTTCTGGATG 34
CD40LG TCATGAAAACGATACAGAGATGC CTTCGTCTCCTCTTTGTTTAACATT 2
CFLAR CACCCAGATTGAGGATGGTC GCTGCCAAAGGAGATTTAACA 48
CYLD TTTGCGTGTGTTGAAAGTACAAT TTCCTGCGTCACACTCTCTG 33
DFFA CGAGCCACATCCTTACTGC TTTGGGGTCTTCCTTGGTAA 7
FAS GTGGACCCGCTCAGTACG TCTAGCAACAGACGTAAGAACCA 60
FASLG CAGTCCACCCCCTGAAAAA GGACCTTGAGTTGGACTTGC 73
GADD45A GGAGAGCAGAAGACCGAAAG AGTGATCGTGCGCTGACTC 37
GFPT1 AGCTGTGCAAACACTCCAGA TTCCTTCTGCATAAATGAACTGAA 67
IGF1R TTCAGCGCTGCTGATGTG AAGTTCCCGGCTCATGGT 7
MCL1 AAGCCAATGGGCAGGTCT TGTCCAGTTTCCGAAGCAT 4
NOL3 AGGCTGAAGCAGAACCAGAG GCTCTGGCCTTCAGGAATC 36
SPATA2 TCGCTCAGCTCCTCTAGCC AGGGCCCGTGTAGGTCTT 67
SYCP2 ACCAATTCCACGACCACTGT GTTTTGTGTTTCTTGTGTAAGTACCAG 61
TGFβ1 ACTACTACGCCAAGGAGGTCAC TGCTTGAACTTGTCATAGATTTCG 31
TNF CAGCCTCTTCTCCTTCCTGAT GCCAGAGGGCTGATTAGAGA 29
TNFRSF11B GAAGGGCGCTACCTTGAGAT GCAAACTGTATTTCGCTCTGG 17
TNFRSF1A CTGCTCCAAATGCCGAAA CGGTCCACTGTGCAAGAAG 39
TNFRSF10A GGAGGCACAGTGTCTGCTG CAGCACCATTTGCTGGAAC 29
TP53 AGGCCTTGGAACTCAAGGAT CCCTTTTTGGACTTCAGGTG 36
TRAF2 AAGTTCCCCTTAACTTGTGACG CAAGTCTTGACGTGGTCCTG 7
XIAP TTTTGGGACATGGATATACTCAGTT AGCACTTTACTTTATCACCTTCACC 68
*Probe number in Universal ProbeLibrary.
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Statistical analysis 
All the tests were performed using SPSS software 
version 20.0. All the tests were 2-sided. P value < 0.05 
was considered as statistical significant.  
Abbreviations
AO: Acridine orange; AVO: Acidic vesicular 
organelles; EBV: Epstein-Barr virus; Ebv-miR-BART7: 
EBV-encoded microRNA BART7; NPC: Nasopharyngeal 
carcinoma; GFPT1: Glutamine-fructose-6-phosphate 
transaminase 1; TGFβ1: Transforming growth factor beta 
1; XIAP: X-linked inhibitor of apoptosis protein.
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